Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on L 1. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel chiral phosphoric acid catalysis enables high-yield antitumor intermediate production with mild conditions and scalable supply chain reliability for global partners.
Patent CN108610304B reveals a novel Pd-catalyzed C-H activation route for diarylsultams, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel metal-free method for high-purity pharmaceutical intermediates ensuring cost reduction and supply chain reliability via patent CN118126005B.
Patent CN114195711B details efficient Pd-catalyzed carbonylation for quinoline-4(1H)-one. Offers cost reduction and scalable supply chain solutions for pharmaceutical intermediates manufacturing.
Patent CN110724164B details novel pyridine-substituted spiro ligands enabling high TON hydrogenation. Ideal for API intermediates.
Patent CN113683595B reveals a sulfur-promoted route for triazoles offering safer scalable manufacturing and cost reduction for pharmaceutical intermediate suppliers globally.
Novel silver-mediated method for high-purity isoquinoline intermediates. Reduces synthetic steps, improves yield, and ensures supply chain stability for pharma manufacturing.
Patent CN111675662B reveals a cost-effective FeCl3-catalyzed route to 2-trifluoromethyl quinazolinones, offering reliable supply chain solutions for API manufacturing.
Novel sulfur-promoted cyclization patent CN116640097B enables cost-effective manufacturing. Delivers high-purity intermediates with enhanced supply chain reliability.
Novel heating-promoted synthesis of 2-trifluoromethyl quinoline intermediates. Metal-free, green chemistry approach ensures cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel metal-free synthesis of trifluoromethyl 1,2,4-triazines via [3+3] cycloaddition. Cost-effective, scalable route for pharma intermediates.
Patent CN113735778B reveals efficient silver oxide promoted route. Delivers high purity intermediates with scalable manufacturing and supply chain stability for global partners.
Novel CuCl-catalyzed route for high-purity triazole intermediates. Reduces cost and simplifies supply chain for pharma manufacturing significantly.
Patent CN113980028A details a novel organocatalytic route for chiral spiro indolones. This method offers mild conditions, high stereoselectivity, and scalable manufacturing for pharmaceutical intermediates.
Novel carbonylation route for quinoline-4(1H)-one. Enhances supply chain reliability and cost efficiency for pharmaceutical intermediate manufacturing.
Patented Cu-catalyzed method for diynes reduces metal waste and enables mild conditions. Ideal for API intermediates. Cost-effective scale-up for global supply chains.
Novel palladium-catalyzed aminocarbonylation route for quinolin-2(1H)-ones using benzisoxazole. High yields, scalable process for pharmaceutical intermediates.
Novel Mo/Cu co-catalyzed method offers high yields and mild conditions for scalable production of bioactive heterocycles.
Patent CN115286553B reveals nickel-catalyzed indole synthesis. Offers cost reduction in pharmaceutical intermediates manufacturing and high-purity supply chain solutions.
Novel Pd-catalyzed aminocarbonylation route offers high yields and broad substrate tolerance for scalable pharmaceutical intermediate production.